Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)
Stopped Sponsor stopped due to difficulties to recruit 402 patients required by protocol
Conditions
Interventions
- DRUG: Bemiparin
- DRUG: Placebo
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Collaborators